On June 2, 2022 JSR Corporation reported that Medical & Biological Laboratories (MBL) and Crown Bioscience, JSR Life Sciences companies, have formed a joint venture to further extend their preclinical services to Japanese customers (Press release, JSR, JUN 2, 2022, View Source [SID1234615399]). The new company named "Crown Bioscience & MBL", provides preclinical and translational services to biopharmaceutical customers in Japan. MBL is currently a distributor for Crown Bioscience and the establishment of the joint venture marks a significant milestone in the long-standing relationship between the two founding companies.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company, established in April 2022, is expected to start service operation from September 2022. For details, please refer to the announcements from Crown Bioscience.